Press Releases

FILTER BY

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

프로스트 앤 설리번, 의료용 3D 프린팅 분야가 의료기기 및 제약 산업에 큰 변화를 줄 것으로 전망

2017년 3월 31일, 대한민국 – 3D 프린팅 기술은 복잡하고 맞춤형의 제품을 효율적으로 생산해야 하는 의료업계의 니즈들을 충족시킬 수 있는 이상적인 솔루션이다. 의료 시장의 수 많은 주요 업체들이 맞춤형 제약과 원료의약품(API: Active Pharmaceutical Ingredients), 의료기기를 만들어 개인 맞춤형 의학 시대를 이끌 수 있다는 판단 아래, 3D 프린팅 도입에 큰 관심을 보였다. 3D 프린팅을 사용하면 맞춤형 복용량의 약물들을 쉽게 얻을 수 있기...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Comments – PSA acquires Opel and Vauxhall

PSA to take Opel/Vauxhall to new profitability as 2nd largest European car manufacturer Olivia Walker | Principal Consultant | Visionary Innovation Group GM selling Opel/Vauxhall and PSA buying it is an action grounded in good business sense – one that is anchored in...

Comment on PSA – Opel Merger

Vishwas Shankar | Research Manager As early as 2012, Opel’s parent company, GM, and PSA decided to work together, by GM taking a 7% stake in PSA. GM sold its stakes in PSA in December 2013. However, since 2012 there was a strong will to collaborate from both GM and...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.